TABLE 1.
Patients characteristic and adverse mucous‐cutaneous reactions in 6 patients after the first dose of Pfizer‐BioNTech vaccine
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|
Gender | Female | Female | Male | Female | Female | Female |
Age | 24 | 31 | 28 | 58 | 44 | 54 |
Personal atopy | Allergic rhinitis | Allergic rhinitis | Allergic rhinitis | Allergic rhinitis and asthma | Allergic rhinitis | Allergic rhinitis, atopic dermatitis |
Allergy history | – | – | – | – | – | Contact allergy (nichel sulphate, fragrances) |
Type of reaction | Generalized acute urticaria | Angioedema (tongue, gums) | Generalized acute urticaria | Flushing of the face | Flushing of the face | Angioedema (tongue, lips) |
Time of onset | 5 min | 24 h | 5 min | 30 min | 20 min | 10 min |
Treatment | Betametasone sodium phosphate (IV) | – | – | – | – | – |